+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bifidobacterium Longum Subsp. Infantis M-63 Market by Application, Form, End User, Distribution Channel - Global Forecast to 2030- Product Image
Bifidobacterium Longum Subsp. Infantis M-63 Market by Application, Form, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Bifidobacterium Longum Subsp. Infantis M-63 Market by Application, Form, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082211
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Bifidobacterium longum subsp. infantis M-63 is positioned at the forefront of innovation within the global probiotic market, uniquely advancing infant microbiome health and immune system modulation. Senior leaders in nutrition, healthcare, and biotechnology can leverage this executive outlook to evaluate evolving opportunities, regulatory shifts, and the strategic landscape surrounding this clinically validated probiotic strain.

Market Snapshot: Bifidobacterium longum subsp. infantis M-63 Market

The global market for Bifidobacterium longum subsp. infantis M-63 is shaped by rising consumer focus on early-life gut health, demand for science-backed infant nutrition, and strategic investments in probiotic research. The sector is characterized by intensified cross-sector collaborations, fast-paced breakthroughs in clinical validation, and adaptive supply chain responses amid a dynamic regulatory environment. Companies are strengthening market positioning through innovation in formulation, shifting distribution models, and enhanced stakeholder engagement.

Scope & Segmentation

  • Application Areas: Animal feed, dietary supplements, functional foods, infant formula, and pharmaceuticals represent key domains. Specific applications include aquaculture, livestock, pet nutrition, adult and elderly supplements, beverages, dairy, snack bars, diversified infant formulas, and adjunctive therapies.
  • Formulations: Capsule (enteric-coated and non-enteric), liquid, powder, and tablet formats enable customization for varied end uses.
  • End Users: Adults, children, elderly populations, and infants form the major consumer groups, each with specialized needs and regulatory considerations.
  • Distribution Channels: Coverage spans direct marketing, healthcare practitioner channels, e-commerce (direct-to-consumer, third-party), hospital procurement (private and public), and retail pharmacies (chain and independent).
  • Geographical Coverage: Key regions analyzed include the Americas (United States, Canada, Latin America), Europe, the Middle East and Africa (including prominent EU and Gulf states), and Asia-Pacific (notably China, India, Japan, and Southeast Asia).
  • Company Landscape: The report profiles major players such as Morinaga Milk Industry Co., Ltd., Danone S.A., Yakult Honsha Co., Ltd., Nestlé S.A., Chr. Hansen A/S, DuPont de Nemours, Inc., Kerry Group plc, Lallemand Inc., BioGaia AB, and Probi AB.

Key Takeaways for Decision-Makers

  • The strong colonization and immune-modulating capacity of Bifidobacterium longum subsp. infantis M-63 support its increasing adoption in premium infant nutrition and therapeutic products.
  • Regulatory developments and consumer demand for clinically validated, transparent, and sustainable products are prompting reformulation, heightened traceability, and ESG integration across the value chain.
  • Technology-enabled precision in formulation—utilizing next-generation sequencing and advanced fermentation—enhances product differentiation and operational efficiency in both established and emerging markets.
  • Localized manufacturing and supply chain diversification are increasingly important as companies respond to policy changes, including new U.S. tariff measures influencing both sourcing strategies and investment in domestic capacities.
  • Growth strategies increasingly rely on partnerships between leading life sciences firms, digital health platforms, and academic research networks, creating competitive advantages and unlocking new distribution models.

Tariff Impact on Market Strategy

Recent U.S. tariff adjustments, enacted in 2025, have complicated the importation of key intermediates from Asia, affecting sourcing and end-product pricing. In response, some manufacturers are nearshoring operations and expanding local production capabilities. Domestic ingredient suppliers gain opportunities, while ongoing trade negotiations and requests for tariff exemptions for health-credentialed strains continue to shape operational decisions. These developments underscore the urgency of diversifying supplier partnerships and investing in vertically integrated manufacturing assets to mitigate cost pressures and maintain market resilience.

Methodology & Data Sources

This analysis is built upon multi-tiered research, combining structured interviews with pediatric specialists, scientists, and procurement professionals, roundtables with regulatory experts, and a systematic review of peer-reviewed journals, clinical trial data, and patents. Insights are cross-verified using proprietary import/export and investment databases. Segmentation reflects real-world buying patterns and formulation practices—each step reviewed by subject matter experts to ensure integrity and relevance.

Why This Report Matters

  • Enables executives to benchmark their own probiotic strategies against leading global and regional players, offering clarity on emerging risks and innovation pathways.
  • Provides a clear framework to evaluate supply chain vulnerabilities and new market opportunities resulting from regulatory and tariff-driven shifts.
  • Offers actionable guidance for investment planning, competitive positioning, and partnerships across the evolving infant microbiome health ecosystem.

Conclusion

Bifidobacterium longum subsp. infantis M-63 continues to influence market dynamics in infant and therapeutic nutrition, propelled by scientific validation and adaptive strategies. Understanding pivotal factors—from regulations to regional trends—enables organizations to unlock growth and secure leadership in this sector.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Application
8.1. Introduction
8.2. Animal Feed
8.2.1. Aquaculture Feed
8.2.2. Livestock Feed
8.2.3. Pet Food
8.3. Dietary Supplements
8.3.1. Adult Supplements
8.3.2. Elderly Supplements
8.3.3. Infant Supplements
8.4. Functional Foods
8.4.1. Beverages
8.4.2. Dairy Products
8.4.3. Snack Bars
8.5. Infant Formula
8.5.1. Cow Milk-Based
8.5.2. Hypoallergenic
8.5.3. Soy-Based
8.6. Pharmaceuticals
8.6.1. Adjunctive Therapies
8.6.2. Probiotic Therapeutics
9. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Form
9.1. Introduction
9.2. Capsule
9.2.1. Enteric-Coated
9.2.2. Non-Enteric
9.3. Liquid
9.4. Powder
9.5. Tablet
10. Bifidobacterium Longum Subsp. Infantis M-63 Market, by End User
10.1. Introduction
10.2. Adults
10.3. Children
10.4. Elderly
10.5. Infants
11. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.2.1. Direct Marketing
11.2.2. Healthcare Practitioner Channel
11.3. E-Commerce
11.3.1. Direct-To-Consumer
11.3.2. Third-Party Platform
11.4. Hospitals
11.4.1. Private Hospital
11.4.2. Public Hospital
11.5. Retail Pharmacies
11.5.1. Chain Pharmacy
11.5.2. Independent Pharmacy
12. Americas Bifidobacterium Longum Subsp. Infantis M-63 Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Morinaga Milk Industry Co., Ltd.
15.3.2. Danone S.A.
15.3.3. Yakult Honsha Co., Ltd.
15.3.4. Nestlé S.A.
15.3.5. Chr. Hansen A/S
15.3.6. DuPont de Nemours, Inc.
15.3.7. Kerry Group plc
15.3.8. Lallemand Inc.
15.3.9. BioGaia AB
15.3.10. Probi AB
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET MULTI-CURRENCY
FIGURE 2. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET MULTI-LANGUAGE
FIGURE 3. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIVESTOCK FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PET FOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULT SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SNACK BARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COW MILK-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HYPOALLERGENIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SOY-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PROBIOTIC THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ENTERIC-COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY NON-ENTERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT MARKETING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HEALTHCARE PRACTITIONER CHANNEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 91. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 93. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 94. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 95. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 96. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 97. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 98. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 99. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 102. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 103. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 109. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 112. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 113. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 116. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 176. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 178. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 179. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 180. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 181. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 182. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 183. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 184. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 187. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 188. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 189. GERMANY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 190. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 192. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 193. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 194. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 195. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 196. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 197. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 198. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 201. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 202. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 203. FRANCE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 218. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 220. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 221. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 222. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 223. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 224. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 225. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 226. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 229. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 230. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 231. ITALY BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 232. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 234. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 235. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 236. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 237. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 238. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 239. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 240. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 243. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 244. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 245. SPAIN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2030 (

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bifidobacterium Longum Subsp. Infantis M-63 market report include:
  • Morinaga Milk Industry Co., Ltd.
  • Danone S.A.
  • Yakult Honsha Co., Ltd.
  • Nestlé S.A.
  • Chr. Hansen A/S
  • DuPont de Nemours, Inc.
  • Kerry Group plc
  • Lallemand Inc.
  • BioGaia AB
  • Probi AB

Related Topics

Related Reports

Bifidobacterium Longum Lysate (CAS 96507-89-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Bifidobacterium Longum Lysate (CAS 96507-89-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Longum Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Longum Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 78 Pages
  • Global
From
Bifidobacterium - Global Strategic Business Report - Product Image

Bifidobacterium - Global Strategic Business Report

  • Report
  • 293 Pages
  • Global
From
Immune Health Supplements Market by Distribution Channel, Form, Ingredient - Global Forecast to 2030 - Product Image

Immune Health Supplements Market by Distribution Channel, Form, Ingredient - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
OTC Probiotics Supplement Market - Forecasts from 2025 to 2030 - Product Image

OTC Probiotics Supplement Market - Forecasts from 2025 to 2030

  • Report
  • 148 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.